single page -

Data Table

Quarterly Table

Date Begin	Date End	Net Sales	Net Profit	Total Income	Diluted EPS for continuing operation	Other Expenses	Other Income	Depreciation and amortisation expense	Profit (+)/ Loss (-) from Ordinary Activities before Tax
2024-01-01	2024-03-31	1,022.35	35.30	1,022.83	2.23	-207.75	0.48	-38.64	39.29
2023-10-01	2023-12-31	973.36	4.98	973.38	0.31	-121.22	0.02	-36.29	0.42
2023-10-01	2023-12-31	973.36	5.00	973.38	0.32	-121.24	0.02	-36.24	0.44
2023-07-01	2023-09-30	815.56	-35.60	815.84	-2.25	-185.37	0.29	-37.30	-47.54
2023-07-01	2023-09-30	0.00	0.00	0.00	-	-	0.00	-	0.00
2023-04-01	2023-06-30	874.68	-95.35	874.88	-6.02	-161.86	0.20	-34.19	-102.85
2023-01-01	2023-03-31	911.07	-43.86	914.00	-2.77	-136.52	2.92	-27.50	-56.49
2022-10-01	2022-12-31	633.27	4.26	634.61	0.27	-153.03	1.35	-28.83	5.03
2022-07-01	2022-09-30	1,083.26	22.26	1,083.26	1.41	-166.96	0.01	-27.56	31.22
2022-04-01	2022-06-30	1,094.95	30.04	1,095.02	1.92	-158.27	0.07	-26.00	42.38
2022-01-01	2022-03-31	1,209.56	66.92	1,209.56	4.23	-151.47	-	-26.87	49.78
2021-10-01	2021-12-31	938.36	40.22	1,018.78	2.54	-118.89	80.42	-26.72	89.54
2021-07-01	2021-09-30	1,142.02	45.28	1,230.23	2.86	-198.26	88.21	-25.01	82.83
2021-04-01	2021-06-30	1,047.78	44.16	1,053.01	2.79	-113.87	5.22	-23.90	55.18
2021-01-01	2021-03-31	907.87	21.54	929.01	1.36	-113.72	21.14	-25.15	68.41
2020-10-01	2020-12-31	886.87	64.34	899.55	4.07	-123.45	12.68	-23.34	91.89
2020-07-01	2020-09-30	970.26	110.87	977.10	7.00	-113.33	6.84	-22.65	134.36
2020-04-01	2020-06-30	1,036.41	82.95	1,042.95	5.24	-101.28	6.55	-20.61	100.53
2020-01-01	2020-03-31	880.95	50.54	885.48	3.19	-102.41	4.53	-20.96	30.54
2019-10-01	2019-12-31	619.44	16.51	626.03	1.04	-91.05	6.59	-20.58	10.16
2019-07-01	2019-09-30	672.73	8.08	673.03	0.51	-83.34	0.30	-22.65	11.40
2019-04-01	2019-06-30	650.42	7.39	650.81	0.47	-95.89	0.39	-17.99	10.43
2019-01-01	2019-03-31	480.89	-60.07	482.94	-3.80	-57.92	2.05	-16.57	-37.13
2018-10-01	2018-12-31	485.83	-44.20	486.28	-2.79	-115.36	0.45	-18.35	-50.78
2018-07-01	2018-09-30	719.01	17.28	719.39	-	-117.92	0.38	-	20.27
2018-04-01	2018-06-30	590.07	6.68	590.35	-	-96.49	0.28	-17.82	10.27
2018-01-01	2018-03-31	671.95	30.55	672.98	-	-110.80	1.03	-25.78	36.07
2017-10-01	2017-12-31	739.07	59.79	745.51	-	-98.08	6.43	-14.77	92.82
2017-07-01	2017-09-30	831.41	66.99	831.78	-	-111.53	0.37	-	103.01
2017-04-01	2017-06-30	597.04	41.56	597.48	-	-141.25	0.44	-12.53	61.58
2017-01-01	2017-03-31	876.01	65.61	876.13	-	-	0.12	-	94.96
2016-10-01	2016-12-31	805.78	61.96	-	-	-	0.37	-12.99	86.46
2016-07-01	2016-09-30	764.99	58.37	-	-	-	0.07	-	81.87
2016-04-01	2016-06-30	669.85	51.03	-	-	-	0.08	-	70.53
2016-01-01	2016-03-31	706.62	55.35	-	-	-	-7.24	-	97.67
2015-10-01	2015-12-31	823.54	37.97	-	-	-	0.15	-	57.97
2015-07-01	2015-09-30	725.56	36.49	-	-	-	0.24	-	46.99
2015-04-01	2015-06-30	695.88	30.53	-	-	-	7.06	-	37.53
2015-01-01	2015-03-31	755.78	34.94	-	-	-	0.03	-	27.61
2014-10-01	2014-12-31	629.46	8.45	-	-	-	-	-	12.95
2014-07-01	2014-09-30	434.99	20.06	-	-	-	0.27	-	21.56
2014-04-01	2014-06-30	386.36	-2.03	-	-	-	0.22	-	-2.03
2014-01-01	2014-03-31	379.24	38.96	-	-	-	0.25	-	30.29
2013-10-01	2013-12-31	380.97	-1.00	-	-	-	0.38	-	-1.00
2013-07-01	2013-09-30	282.13	-9.69	-	-	-	-	-	-9.69
2013-04-01	2013-06-30	184.44	-58.66	-	-	-	0.20	-	-58.66
2013-01-01	2013-03-31	461.72	9.66	-	-	-	5.09	-	-40.34

Date Begin	Date End	Net Sales	Net Profit	Total Income	Diluted EPS for continuing operation	Other Expenses	Other Income	Depreciation and amortisation expense	Profit (+)/ Loss (-) from Ordinary Activities before Tax
2024-01-01	2024-03-31	1,022.35	35.30	1,022.83	2.23	-207.75	0.48	-38.64	39.29
2023-10-01	2023-12-31	973.36	5.00	973.38	0.32	-121.24	0.02	-36.24	0.44
2023-10-01	2023-12-31	973.36	4.98	973.38	0.31	-121.22	0.02	-36.29	0.42
2023-07-01	2023-09-30	0.00	0.00	0.00	-	-	0.00	-	0.00

Compounded Data

Standalone

Consolidated

Compounded Sales Growth
10 Years:	12%
5 Years:	10%
3 Years:	-1%
TTM:	-1%

Compounded Profit Growth
10 Years:	0%
5 Years:	-3%
3 Years:	0%
TTM:	-813%

Stock Price CAGR
10 Years:	27%
5 Years:	30%
3 Years:	-12%
1 Year:	3%

Compounded Sales Growth
10 Years:	0%
5 Years:	0%
3 Years:	0%
TTM:	0%

Compounded Profit Growth
10 Years:	0%
5 Years:	0%
3 Years:	0%
TTM:	0%

Stock Price CAGR
10 Years:	27%
5 Years:	30%
3 Years:	-12%
1 Year:	3%

Latest News

Mangalam Drugs and Organics Limited - Financial Results For Quarter Ended December 31, 2022
Mangalam Drugs and Organics Limited has reported its financial results for the quarter ended December 31, 2022. The net sales of the company for the quarter were Rs. 1,138.46 crores, a growth of 8.6% over the previous quarter and 23.2% over the corresponding quarter of the previous year.
Mangalam Drugs And Organics bags order worth Rs 375 crore from US-based firm
Mangalam Drugs and Organics (MDOL) has received an order worth Rs 375 crore from a US-based firm for the supply of active pharmaceutical ingredients (APIs). The order is to be executed over a period of three years.
Mangalam Drugs and Organics plans to set up a new manufacturing facility in Gujarat
Mangalam Drugs and Organics Limited (MDOL) is planning to set up a new manufacturing facility in Gujarat. The new facility will be spread over an area of 50 acres and will have a capacity to produce 1,000 tonnes of APIs per year.

Mangalam Drugs and Organics Ltd.

Short Description

Long Description

Price Chart

Volume Chart

Peer Comparison

Peer Comparison Chart

Quarterly Table